214 related articles for article (PubMed ID: 21517778)
1. Medicinal chemistry of sirtuin inhibitors.
Chen L
Curr Med Chem; 2011; 18(13):1936-46. PubMed ID: 21517778
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
Neugebauer RC; Sippl W; Jung M
Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
[TBL] [Abstract][Full Text] [Related]
4. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
Trapp J; Jochum A; Meier R; Saunders L; Marshall B; Kunick C; Verdin E; Goekjian P; Sippl W; Jung M
J Med Chem; 2006 Dec; 49(25):7307-16. PubMed ID: 17149860
[TBL] [Abstract][Full Text] [Related]
5. The Current State of NAD
Schiedel M; Robaa D; Rumpf T; Sippl W; Jung M
Med Res Rev; 2018 Jan; 38(1):147-200. PubMed ID: 28094444
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
Huber K; Schemies J; Uciechowska U; Wagner JM; Rumpf T; Lewrick F; Süss R; Sippl W; Jung M; Bracher F
J Med Chem; 2010 Feb; 53(3):1383-6. PubMed ID: 20030343
[TBL] [Abstract][Full Text] [Related]
7. Targeting Sirtuins: Substrate Specificity and Inhibitor Design.
Rajabi N; Galleano I; Madsen AS; Olsen CA
Prog Mol Biol Transl Sci; 2018; 154():25-69. PubMed ID: 29413177
[TBL] [Abstract][Full Text] [Related]
8. Development of Second Generation Activity-Based Chemical Probes for Sirtuins.
Curry AM; Barton E; Kang W; Mongeluzi DV; Cen Y
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375102
[TBL] [Abstract][Full Text] [Related]
9. Anticancer agents targeted to sirtuins.
Kozako T; Suzuki T; Yoshimitsu M; Arima N; Honda S; Soeda S
Molecules; 2014 Dec; 19(12):20295-313. PubMed ID: 25486244
[TBL] [Abstract][Full Text] [Related]
10. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
Schemies J; Uciechowska U; Sippl W; Jung M
Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
[TBL] [Abstract][Full Text] [Related]
11. How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
Kumar A; Chauhan S
Eur J Med Chem; 2016 Aug; 119():45-69. PubMed ID: 27153347
[TBL] [Abstract][Full Text] [Related]
12. Biology, Chemistry, and Pharmacology of Sirtuins.
Bedalov A; Chowdhury S; Simon JA
Methods Enzymol; 2016; 574():183-211. PubMed ID: 27423863
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
[TBL] [Abstract][Full Text] [Related]
14. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
Trapp J; Jung M
Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
You W; Steegborn C
J Med Chem; 2018 Dec; 61(23):10922-10928. PubMed ID: 30395713
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.
Rajabi N; Auth M; Troelsen KR; Pannek M; Bhatt DP; Fontenas M; Hirschey MD; Steegborn C; Madsen AS; Olsen CA
Angew Chem Int Ed Engl; 2017 Nov; 56(47):14836-14841. PubMed ID: 29044784
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.
McCarthy AR; Pirrie L; Hollick JJ; Ronseaux S; Campbell J; Higgins M; Staples OD; Tran F; Slawin AM; Lain S; Westwood NJ
Bioorg Med Chem; 2012 Mar; 20(5):1779-93. PubMed ID: 22304848
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.
Dewanjee S; Vallamkondu J; Kalra RS; Chakraborty P; Gangopadhyay M; Sahu R; Medala V; John A; Reddy PH; De Feo V; Kandimalla R
Cells; 2021 May; 10(6):. PubMed ID: 34071497
[TBL] [Abstract][Full Text] [Related]
19. Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.
Xia J; Tilahun EL; Kebede EH; Reid TE; Zhang L; Wang XS
J Chem Inf Model; 2015 Feb; 55(2):374-88. PubMed ID: 25633490
[TBL] [Abstract][Full Text] [Related]
20. An update on lysine deacylases targeting the expanding "acylome".
Olsen CA
ChemMedChem; 2014 Mar; 9(3):434-7. PubMed ID: 24375937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
